Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

Obesity Clinical Trial

Official title:

Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06105164
• Other study ID #: 2023P002811
• Status: Not yet recruiting
• Phase: N/A
• Start date: February 2024
• Est. completion date: August 2028

Study information

• Verified date: October 2023
• Source: Brigham and Women's Hospital
• Contact: Laura Holsen, PhD
• Phone: 617-525-8772
• Email: lholsen[@]bwh.harvard.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study satiety in healthy individuals. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study, the investigators will be stimulating the brain to learn more about the role of the cerebellum in satiety.

Description:

The purpose of this study is to conduct a circuit manipulation experiment to test the hypothesis that targeting the cerebellum can alter activity in response to food cues to advance the understanding of the involvement of the cerebellar-striatal circuit in feeding behavior. Participants will undergo an initial screening session to complete informed consent and undergo baseline assessments including physical activity and food craving. Participants will additionally undergo an MRI scan that includes structural and resting-state functional magnetic resonance imaging (rsfMRI). These rsfMRI imagines will be used to isolate individual resting state networks for targeting of rTMS modulation. Participants will then complete two separate testing sessions involving MRI imaging and food intake assessments before and after rTMS. One visit will involve consumption of a filling meal; the other visit will be completed following an overnight fast.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 150
• Est. completion date: August 2028
• Est. primary completion date: August 2028
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Healthy individuals aged 18 to 65
• BMI of 20-35.0 kg/m2
• Normal or corrected-to-normal vision
• Good general health
• Ability to understand and willingness to sign written informed consent document

Exclusion Criteria:

• Current and/or past medical conditions
• Current and/or past eating disorder
• On a restricted diet and/or taking weight loss medication(s)
• History of bariatric surgery
• Weight fluctuation >3% in past 3 months
• Recent history of illicit recreational drug abuse
• Current nicotine use
• Intellectual disability
• Conditions that might result in increased risks of side effects or complications from TMS or MRI

Related Conditions & MeSH terms

• Appetitive Behavior
• Obesity

Intervention

Device:
• Repetitive Transcranial Magnetic Stimulation (rTMS)
rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry. Intermittent theta burst stimulation (iTBS) consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses (82), will be applied to the target. Cerebellar stimulation will be applied to the targets at 100% of aMT or 35% maximal stimulator output, whichever is higher.
• Sham repetitive Transcranial Magnetic Stimulation (rTMS)
rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry. Intermittent theta burst stimulation (iTBS) consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses (82), will be applied to the target. Cerebellar stimulation will be applied to the targets at 100% of aMT or 35% maximal stimulator output, whichever is higher. Sham is achieved by using a coil with a magnetic shield preventing magnetic field from reaching the head.

Locations

Country	Name	City	State
United States	McLean Hospital	Belmont	Massachusetts
United States	Brigham and Women's Hospital	Boston	Massachusetts

Sponsors (3)

Lead Sponsor	Collaborator
Brigham and Women's Hospital	Beth Israel Deaconess Medical Center, Mclean Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in BOLD response in the cerebellum	Change in functional activation of the cerebellum will be assessed before (pre-TMS) and after (post-rTMS) rTMS stimulation, measured separately at the fed visit and at the fasted visit.	30 minutes pre-TMS and 30 minutes post-TMS, at each of two main study visits (fed, fasted)
Primary	Change in BOLD response in the ventral striatum	Change in functional activation of the ventral striatum will be assessed before (pre-TMS) and after (post-rTMS) rTMS stimulation, measured separately at the fed visit and at the fasted visit.	30 minutes pre-TMS and 30 minutes post-TMS, at each of two main study visits (fed, fasted)
Primary	Change in food reward valuation	Change in food reward valuation of high-calorie foods will be assessed using the Willingness to Pay task, measured before (pre-TMS) and after (post-rTMS) rTMS stimulation, measured separately at the fed visit and at the fasted visit.	up to 60 minutes pre-TMS and up to 60 minutes post-TMS, at each of two main study visits (fed, fasted)
Primary	Ad libitum snack food intake	Change in total caloric intake during the ad libitum snack food session will be assessed at the baseline visit and after (post-rTMS) rTMS stimulation, the latter measured separately at the fed visit and at the fasted visit.	baseline, up to 60 minutes post-TMS at each of two main study visits (fed, fasted)